Wednesday, June 30, 2021

Zydus’ COVID-19 vaccine shows 66.6% efficacy in Phase-3 interim analysis, company files for emergency use

Zydus’ COVID-19 vaccine shows 66.6% efficacy in Phase-3 interim analysis, company files for emergency use No moderate case of COVID-19 disease was observed in the vaccine arm post administration of the third dose suggesting 100% efficacy for moderate disease. No severe cases or deaths due to COVID-19 occurred in the vaccine arm after administration of the second dose of the vaccine.

from Moneycontrol Business News https://www.moneycontrol.com/news/business/zydus’-covid-19-vaccine-shows-666-efficacyphase-3-interim-analysis-company-files-for-emergency-use_15245821.html

No comments:

Post a Comment

Russia says it has handed over 6,060 Ukrainian soldiers' bodies, ready to return more

Russia has given back the bodies of 6,060 Ukrainian soldiers. This happened under agreements from talks in Istanbul. Vladimir Medinsky from ...